The ONTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ONTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ONTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ONTX Detailed Price Forecast - CNN Money||View ONTX Detailed Summary - Google Finance|
|View ONTX Detailed Summary - Yahoo! Finance||View ONTX Stock Research & Analysis - Zacks.com|
|View ONTX Trends & Analysis - Trade-Ideas||View ONTX Major Holders - Barrons|
|View ONTX Call Transcripts - NASDAQ||View ONTX Breaking News & Analysis - Seeking Alpha|
|View ONTX Annual Report - CompanySpotlight.com||View ONTX OTC Short Report - OTCShortReport.com|
|View ONTX Fundamentals - TradeKing||View ONTX SEC Filings - Bar Chart|
|View Historical Prices for ONTX - The WSJ||View Performance/Total Return for ONTX - Morningstar|
|View the Analyst Estimates for ONTX - MarketWatch||View the Earnings History for ONTX - CNBC|
|View the ONTX Earnings - StockMarketWatch||View ONTX Buy or Sell Recommendations - MacroAxis|
|View the ONTX Bullish Patterns - American Bulls||View ONTX Short Pain Metrics - ShortPainBot.com|
|View ONTX Stock Mentions - StockTwits||View ONTX Stock Mentions - PennyStockTweets|
|View ONTX Stock Mentions - Twitter||View ONTX Investment Forum News - Investor Hub|
|View ONTX Stock Mentions - Yahoo! Message Board||View ONTX Stock Mentions - Seeking Alpha|
|View Insider Transactions for ONTX - SECform4.com||View Insider Transactions for ONTX - Insider Cow|
|View ONTX Major Holdings Summary - CNBC||View Insider Disclosure for ONTX - OTC Markets|
|View Insider Transactions for ONTX - Yahoo! Finance||View Institutional Holdings for ONTX - NASDAQ|
|View ONTX Stock Insight & Charts - FinViz.com||View ONTX Investment Charts - StockCharts.com|
|View ONTX Stock Overview & Charts - BarChart||View ONTX User Generated Charts - Trading View|
Free Technical Research on OPKO Health and Three More Biotech Equities
Posted on Tuesday July 17, 2018
On Monday, July 16, 2018, the NASDAQ Composite and the S&P 500 edged 0.26% and 0.10% lower, respectively at the closing bell, while the Dow Jones Industrial Average stayed bullish, finishing marginally higher by 0.18%. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Onconova Therapeutics Inc. (NASDAQ: ONTX), Ophthotech Corp. (NASDAQ: OPHT), OPKO Health Inc. (NASDAQ: OPK), and OvaScience Inc. (NASDAQ: OVAS).
Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.
Posted on Thursday June 21, 2018
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced the promotion of Dr. Steven M. Fruchtman. In his new role as President, Dr. Fruchtman will have oversight over the entire product portfolio, as well as a key role in all other areas of the Company. Dr. Fruchtman will continue to report to Dr. Ramesh Kumar, co-founder and Chief Executive Officer of the Company.
Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association
Posted on Thursday June 07, 2018
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced a presentation at the 23rd Congress of the European Hematology Association being held June 14-17, 2018 in Stockholm, Sweden. Dr. Steven Fruchtman, Onconova’s Chief Medical Officer and Senior VP, Research & Development, will be attending the conference. A copy of the poster and oral presentation will be available by visiting "Scientific Presentations" in the Investors section of Onconova's website immediately following the event.
Onconova Therapeutics, Inc. to Present at the 8th Annual LD Micro Invitational
Posted on Tuesday May 29, 2018
LOS ANGELES, CA / ACCESSWIRE / May 29, 2018 / Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), today announced that it will be presenting at the 8th Annual LD Micro Invitational on Monday, June 4th at 9:00a PDT / 12:00p EDT at the Luxe Sunset Bel Air Hotel in Los Angeles. Mr. Mark Guerin, Chief Financial Officer of Onconova, will be giving the presentation and meeting with investors. "The event is slated to be our largest Invitational to date," stated Chris Lahiji, President of LD Micro.